Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Liabilities from Discontinued Operations (2022 - 2024)

Historic Liabilities from Discontinued Operations for Perspective Therapeutics (CATX) over the last 3 years, with Q1 2024 value amounting to $5.1 million.

  • Perspective Therapeutics' Liabilities from Discontinued Operations changed N/A to $5.1 million in Q1 2024 from the same period last year, while for Mar 2024 it was $5.1 million, marking a year-over-year change of. This contributed to the annual value of $5.1 million for FY2023, which is 143232.63% up from last year.
  • Latest data reveals that Perspective Therapeutics reported Liabilities from Discontinued Operations of $5.1 million as of Q1 2024.
  • In the past 5 years, Perspective Therapeutics' Liabilities from Discontinued Operations registered a high of $5.1 million during Q4 2023, and its lowest value of $331000.0 during Q4 2022.
  • Moreover, its 3-year median value for Liabilities from Discontinued Operations was $5.1 million (2024), whereas its average is $3.5 million.
  • Data for Perspective Therapeutics' Liabilities from Discontinued Operations shows a peak YoY increase of 143232.63% (in 2023) and a maximum YoY decrease of 143232.63% (in 2023) over the last 5 years.
  • Quarter analysis of 3 years shows Perspective Therapeutics' Liabilities from Discontinued Operations stood at $331000.0 in 2022, then soared by 1432.33% to $5.1 million in 2023, then decreased by 0.04% to $5.1 million in 2024.
  • Its Liabilities from Discontinued Operations stands at $5.1 million for Q1 2024, versus $5.1 million for Q4 2023 and $331000.0 for Q4 2022.